CELLPOINT vs JARO: Stock Comparison
JARO INS OF TEC MG N RE L is the larger company by market capitalisation. CELLPOINT shows faster revenue growth, while JARO INS OF TEC MG N RE L shows a higher ROE, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
CELLPOINT leads 3; JARO leads 8 of 11
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | CELLPOINT | JARO |
|---|---|---|
| Sector | — | Consumer Services |
| Industry | — | E-Learning |
Price
| Metric | CELLPOINT | JARO |
|---|---|---|
| Live Price | — | ₹465.4 |
| Day Change | — | -1.2% |
| Volume | — | 98,491 |
| 52-Week High | — | ₹890 |
| 52-Week Low | — | ₹383.5 |
| Distance from 52W High | — | -47.71% |
Valuation
| Metric | CELLPOINT | JARO |
|---|---|---|
| Market Cap | ₹27 Cr | ₹1,040 Cr |
| P/E Ratio | — | 17.83x |
| P/B Ratio | — | 2.8x |
| EPS | ₹0.03 | ₹5.02 |
| Book Value | ₹39.77 | ₹161.84 |
| Dividend Yield | 0% | 1.07% |
Growth
| Metric | CELLPOINT | JARO |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | -1.8% |
| EPS Growth (TTM YoY) | 0% | 3.9% |
| Qtr Sales Growth | 107.94% | -74.17% |
| Qtr Profit Growth | -66.67% | -78.89% |
Profitability & Leverage
| Metric | CELLPOINT | JARO |
|---|---|---|
| ROE | 0.09% | 14.68% |
| ROCE | 0.34% | 16.42% |
| Net Margin | 0% | 17.05% |
| Operating Margin | 2.01% | 26.81% |
| Debt to Equity | 1.04x | 0x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | CELLPOINT | JARO |
|---|---|---|
| Promoter Holding | 73.06% | 61.43%▲ 4.15 pp |
| FII Holding | 0% | 0.75%▼ 0.04 pp |
| DII Holding | 0% | 2.7%▼ 2.17 pp |
| Public Holding | 26.94% | 33.32%▼ 3.75 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: CELLPOINT and JARO INS OF TEC MG N RE L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.